SABAKEM TRIFLURALIN 480EC SELECTIVE HERBICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sabakem trifluralin 480ec selective herbicide

sabakem pty ltd - trifluralin; liquid hydrocarbon; liquid hydrocarbon; liquid hydrocarbon - emulsifiable concentrate - trifluralin anilide/aniline-dinitro active 480.0 g/l; liquid hydrocarbon solvent other 562.0 g/l; liquid hydrocarbon solvent other 480.0 g/l; liquid hydrocarbon solvent other 475.0 g/l - herbicide - adzuki bean | barley | barley - prior to sowing & incorporated | borlotti bean | broccoli - direct seeded | broccoli transplants - amaranth or amaranthus | amsinckia,yellow burrweed or burr grass | annual grasses - see label | annual phalaris | annual ryegrass | annual ryegrass - seed | annual ryegrass - suppression | barley grass | barnyard grass or water grass | barnyard or water grass - seed | broadleaf weeds | brome grass | brome grass - suppression | button grass | caltrop or yellow vine | caltrop or yellow vine - seed | caltrop or yellow vine - suppression | canary grass | capeweed | cereal oat | climbing buckwheat - suppression | columbus grass - seed | common pigweed | corn gromwell, ironweed or sheepweed | crowsfoot grass | deadnettle | deadnettle - suppression | fumitory | fumitory - red | fumitory - seed | fumitory - white | geranium | giant or black pigweed | guinea grass - seed | iceplant - suppression | indian hedge mustard | ivy leaf speedwell | johnson grass - seed | liverseed grass - seed | lovegrass | mossman river or burr grass | mustard | paradoxa grass | phalaris - phalaris spp. | pink fumitory - seedling | radish |

APPARENT GLYPHOSATE 510 K HERBICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apparent glyphosate 510 k herbicide

apparent pty. ltd. - glyphosate present as the potassium salt - soluble concentrate - glyphosate present as the potassium salt glycine active 510.0 g/l - herbicide - adzuki beans - pre-harvest | agricultural area - general | almond | avocado | banana | blueberry | chickpea - pre-harvest | citr - african lovegrass | african turnip weed | amaranth or amaranthus | amsinckia | annual grasses - see label | annual ground cherry | annual phalaris | annual ryegrass | annual weeds | artichoke thistle | bamboo | barley grass | barnyard grass or water grass | barnyard or water grass | bathurst burr | bitou bush or boneseed | blackberry | bladder ketmia | blady grass | boggabri weed | boxthorn | bracken | brome grass | browntop bent | button grass | calomba daisy | caltrop or yellow vine | camel or afghan melon | canary grass | capeweed | carpet grass | cat's ear or flatweed | caustic weed | chickweed | chinese scrub | climbing buckwheat | cobbler's pegs | cocksfoot | columbus grass | couch | crofton weed | deadnettle | dock | dock - seedling | english couch or rope twitch | erodium spp. | eucalyptus - seedling up to 2 m tall | fumitory | furze or gorse | giant or black pigweed | grain sorghum - post harvest | grain sorghum - pre harvest | ground cherry - physalis angulata | groundsel bush | guinea grass | hawth

BIFLEX AQUAMAX INSECTICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

biflex aquamax insecticide

fmc australasia pty ltd - bifenthrin - suspension concentrate - bifenthrin pyrethroid active 100.0 g/l - insecticide - building protection from termite attack | commercial area - general | commercial building/structure - external | commercial buil - ants (except red imported fire ant) | biting midge | cockroach | flea | fly | mosquito | paper nest wasp | spider | subterranean termite | tick | adult mosquitoes | ctenocephalides spp. | ground fleas | large cockroach | papernest wasps | small cockroach

SET-UP 450 HERBICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

set-up 450 herbicide

imaspro resources sdn bhd - glyphosate present as the isopropylamine salt - aqueous concentrate - glyphosate present as the isopropylamine salt glycine active 450.0 g/l - herbicide - agricultural area - general | annual grass weed - seed set control | avocado | banana | blueberry | calomba daisy seed set contr - african lovegrass | amaranth or amaranthus | amsinckia | annual or wimmera ryegrass | annual phalaris | annual ryegrass | annual ryegrass - suppression | artichoke thistle | australian bluebell - w. stricta | bamboo (bambusa spp.) | barbed wire grass | barley grass | barnyard grass or water grass | bent grass - agrostis capillaris | bent grass - agrostis tenuis | bitou bush or boneseed | black speargrass | blackberry | bladder ketmia | blady grass | boggabri weed | boxthorn | bracken | brome grass | brome grass - bromus unioloides | burr medic | californian thistle | calomba daisy | caltrop - tribulis terrestis | caltrop or yellow vine | canary grass | canary grasses | capeweed | carpet grass | cat's ear or flatweed | chickweed | chinese scrub | cobbler's pegs | cocksfoot | couch | crofton weed | cudweed | dock | dock - seedling | english couch or rope twitch | erodium, crowfoot or storksbill | fumitory | grain sorghum - pre harvest | ground cherry - physalis angulata | ground or annual ground cherry | ground

AUSGRO SHARP SHOOTER LIME SULPHUR INSECTICIDE/FUNGICIDE CONCENTRATE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ausgro sharp shooter lime sulphur insecticide/fungicide concentrate

duluxgroup (australia) pty ltd - sulfur (s) present as polysulfide sulfur - aqueous concentrate - sulfur (s) present as polysulfide sulfur mineral-sulfur active 200.0 g/l - fungicide - apple crop = apple orchard | apricot | fruit crop or tree | nectarine | peach | plum | prune plum | rose | rosaceae | sturt's de - black spot/scab in apple/pear | carmine mite | freckle or scab on stone fruit | leaf curl | peach aphid | powdery mildew | powdery mildew on pome | scale | shothole | stone fruit rust | apple scab | black peach aphid | cercospora | clasterosporium | freckle (scab) | fructicola | green peach aphid | pear scab | phyllos | red spider mite | shot hole | spider mite | transzchelia pruni-spinosae | two-spotted mite | two-spotted spider mite | venturia pirina

NARCAN- naloxone hydrochloride spray
NARCAN- naloxone hydrochloride spray United States - English - NLM (National Library of Medicine)

narcan- naloxone hydrochloride spray narcan- naloxone hydrochloride spray

emergent devices inc. - naloxone hydrochloride (unii: f850569pqr) (naloxone - unii:36b82amq7n) - naloxone hydrochloride 2 mg in 0.1 ml - narcan nasal spray is indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. narcan nasal spray is intended for immediate administration as emergency therapy in settings where opioids may be present. narcan nasal spray is not a substitute for emergency medical care. limitations of use: restrict prescription of narcan nasal spray 2 mg to opioid-dependent patients expected to be at risk for severe opioid withdrawal in situations where there is a low risk for accidental or intentional opioid exposure by household contacts. narcan nasal spray is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the other ingredients. risk summary the limited available data on naloxone use in pregnant women are not sufficient to inform a drug-associated risk. however, there are clinical considerations [see clinical considerations] . in animal reproduction studies, no embryotoxic or teratogenic ef

NARCAN- naloxone hydrochloride spray United States - English - NLM (National Library of Medicine)

narcan- naloxone hydrochloride spray

a-s medication solutions - naloxone hydrochloride (unii: f850569pqr) (naloxone - unii:36b82amq7n) - narcan nasal spray is indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. narcan nasal spray is intended for immediate administration as emergency therapy in settings where opioids may be present. narcan nasal spray is not a substitute for emergency medical care. limitations of use: restrict prescription of narcan nasal spray 2 mg to opioid-dependent patients expected to be at risk for severe opioid withdrawal in situations where there is a low risk for accidental or intentional opioid exposure by household contacts. narcan nasal spray is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the other ingredients. risk summary the limited available data on naloxone use in pregnant women are not sufficient to inform a drug-associated risk. however, there are clinical considerations [see clinical considerations] . in animal reproduction studies, no embryotoxic or teratogenic ef

NITROLINGUAL- nitroglycerin spray United States - English - NLM (National Library of Medicine)

nitrolingual- nitroglycerin spray

allegis pharmaceuticals, llc - nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3) - nitrolingual pumpspray is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. do not use nitrolingual pumpspray in patients who are taking pde-5-inhibitors, such as avanafil, sildenafil, tadalafil, or vardenafil. concomitant use can cause severe hypotension, syncope, or myocardial ischemia [see drug interactions (7.1) ]. do not use nitrolingual pumpspray in patients who are taking soluble guanylate cyclase (sgc) stimulators, such as riociguat. concomitant use can cause hypotension. nitrolingual pumpspray is contraindicated in patients with severe anemia (large doses of nitroglycerin may cause oxidation of hemoglobin to methemoglobin and could exacerbate anemia). nitrolingual pumpspray  may precipitate or aggravate increased intracranial pressure and thus should not be used in patients with possible increased intracranial pressure (e. g. cerebral hemorrhage or traumatic brain injury). nitrolingual pumpspray is contraindicated in patients who are allergic to nitroglycerin, other nitrates or nitrites or any excipient. nitrolingual pumpspray is contraindicated in patients with acute circulatory failure or shock. risk summary limited published data on the use of nitroglycerin are insufficient to determine a drug associated risk of major birth defects or miscarriage. in animal reproduction studies, there were no adverse developmental effects when nitroglycerin was administered intravenously to rabbits or intraperitoneally to rats during organogenesis at doses greater than 64-times the human dose [see data]. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 – 4% and 15 – 20%, respectively. data animal data no embryotoxic or postnatal development effects were observed with transdermal application in pregnant rabbits and rats at doses up to 240 mg/kg/day for 13 days, at intraperitoneal doses in pregnant rats up to 20 mg/kg/day for 11 days, and at intravenous doses in pregnant rabbits up to 4 mg/kg/day for 13 days. risk summary sublingual nitroglycerin has not been studied in lactating women. it is not known if nitroglycerin is present in human milk or if nitroglycerin has effects on milk production. the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for nitroglycerin and any potential adverse effects on the breastfed child from nitroglycerin or from the underlying maternal condition. safety and effectiveness of nitroglycerin in pediatric patients have not been established. clinical studies did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. other reported clinical experience has not identified differences in responses between elderly (greater than or equal to 65 years) and younger (less than 65 years) patients. in general, dose selection for an elderly patient should start at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.